z-logo
open-access-imgOpen Access
Survey of Twitter Viewpoint on Application of Drugs by VADER Sentiment Analysis among Distinct Countries
Author(s) -
Rajesh Bose,
P. S. Aithal,
Sandip Roy
Publication year - 2021
Publication title -
international journal of management, technology, and social science
Language(s) - English
Resource type - Journals
ISSN - 2581-6012
DOI - 10.47992/ijmts.2581.6012.0132
Subject(s) - sentiment analysis , viewpoints , social media , computer science , cluster analysis , homogeneous , globe , rumor , data science , information retrieval , psychology , artificial intelligence , world wide web , mathematics , political science , public relations , art , combinatorics , neuroscience , visual arts
Who does not know that Twitter is an august social networking podium now? Here the folks around the globe are able to establish their viewpoints. Every day, almost 500 million tweets are established in twitter, and this volume contains 8TB data. The data that we derive from twitter is very much significant if we illustrate it, because we are able to derive significant news in the mode of sentiment analysis. From Twitter data, we get to know about the information and remarks of the augmentation of various product, novel fashion etc. Exploration of emotions, viewpoints, subjectivity and motive from a normal message or tweet for the application of drugs for the therapy of COVID-19, is the prime objective of this sentiment analysis. Now, comes clustering. It’s a method by which one can detect homogeneous substances, combine together and create a class or cluster. There was an initiative from of going on with a research from our end and the result of it showed that the implementation of clustering is able to get infirm and solid positive or negative tweets while getting clustered with outcomes of distinct dictionaries and present robust scaffolding on our prediction. The research analyzes the polarity calculation, applying VADER sentiment analysis for the application of drug for the therapy of COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here